Efficacy Evaluation of Bevacizumab Combined with Capecitabine in the Treatment of HER2-Negative Metastatic Breast Cancer: A Meta-Analysis

Figure 5

Forest chart and subgroup analysis of bevacizumab combined with capecitabine for ORR results.